Clinical Update: Highlighting the Outcome of a Clinical Trial with TCR-T targeting NYESO1

Time: 3:00 pm
day: Day Two


  • Using small inhibitory RNA to downregulate the endogenous T cell receptors
  • Clinical results of an investigator initiated in house manufactured clinical trial
  • TCR T product showing efficacy targeting NYESO1